_______________________________________________________
Welcome to the second edition of “RETIREE CAATNIPS”. This newsletter is
produced on behalf of the CAAT Retiree Group Insurance Advisory Committee. It
is designed to keep you informed of changes to your retiree group insurance benefits’ plan as well as give you some helpful information with regard to your
benefits and how to use them. In Volume 2 we will bring you up to date on changes to the Extended Health
Care (EHC) plan, provide general plan information and identify other initiatives that may impact you as a retiree.
Plan changes effective February 1, 2012 Generic drugs will be reimbursed at 100% under EHC Plan 1
o Reimbursement under EHC Plan 1 for generic drugs has been paid at
85%. With this change, and with the use of the drug card, when you have a prescription filled for a generic drug, you will no longer be required
Repairs to eyeglasses/frames will be covered subject to the plan maximum
On-Line Access for Claims If you wish to check the status of a claim that you have submitted to Sun Life, it is easy to do by accessing your records on line by following these steps:
o If you do not have access click on Register Now To view the prior edition(s) of RETIREE CAATNIPS, please visit the Council’s website at www.theCouncil.on.ca . Click on Benefits Information and then click
Retiree Benefits. This will take you to the page that provides a range of retiree related information, including CAATNIPS
“The General Store” - General Plan Information Generic Drugs and your pharmacist
Pharmacists in Ontario are required to dispense the generic version of a
drug that has been prescribed for you where the generic is less expensive
than the brand name drug. The exceptions are
________________________________________________________________________ Volume 2 – November 2011
CAAT Retiree Group Insurance Advisory Committee
_______________________________________________________
• Where there is no generic version • When the generic version is not available • When your doctor writes “no substitution” on your prescription for the
Please accumulate claims before submitting as each reimbursement
• While it’s always good to get your costs covered by the plan, there are
times when claiming an expense is not good for the plan – that’s when it costs the plan more to pay a claim than the claim is worth.
What can the drug card be used for, other than drugs?
Diabetic needles and related supplies when you purchase insulin using the
card. In addition, by using the drug card, the mark-up that the pharmacy
can apply will be limited • Note: In Ontario, the Assistive Devices Program (ADP) under the
Ontario Drug Benefit (ODB) Plan covers needles and syringes for
persons 65 or over who require insulin, up to an annual maximum of $170. Claim through ADP first.
Vaccines and the drug card do not mix!
You cannot use the drug card to purchase vaccines.
• The CAAT Plan covers vaccines that legally require a prescription. If
you do attempt to purchase a vaccine with the drug card you will get a
decline message from the pharmacist (despite having a prescription and despite the vaccine being eligible under the plan).
Provincial Medicare Coverage for Smoking Cessation Medications
Beginning August 4, 2011, the Ontario government started to fund the smoking cessation drugs Champix and Zyban under the ODB Plan. The two drugs
are prescription therapies and meant to be used as part of a comprehensive quit-
smoking plan that includes education and counselling. Quebec has covered anti-smoking drugs since 2000 and Saskatchewan also covers both Champix and Zyban.
Reminders! No Travel Insurance coverage under any of the Extended Health Care Plans.
BEST ADVICE: Don’t leave applying for Travel Insurance coverage to the
last minute and read the small print. If you have a health condition,
________________________________________________________________________ Volume 2 – November 2011
CAAT Retiree Group Insurance Advisory Committee
_______________________________________________________
disclose it up-front so that you understand what coverage you do and do
Effective January 1, 2010, medications that do not have a Drug Identification
Number (DIN) are no longer covered under the CAAT Plans. In January 2010, Health Canada re-classified a number of medications to Natural Health
Products and gave them a Natural Health Product Number (NPN).
How You Can Assist in Controlling Plan Costs Claim your medical expense under your provincial medicare plan first.
Claim only the unpaid balances or items ineligible under your provincial
If you are prescribed a medication for the first time get only a limited supply
to ensure that you are not allergic and have to throw them out.
If you are on maintenance drugs request a 100 day supply which provides a
Sign up for direct deposit and for electronic Explanation of Benefits (EOB),
this will ensure that you receive your payment if another mail strike occurs
Accumulate claims before submitting as each reimbursement cheque costs
Did You Know? – Review these steps before you file your Income Tax
The annual premiums you pay for your Extended Health and/or Dental
Care Plan(s) are considered eligible medical expenses under the Income
Tax Act. Your College will issue you a statement on an annual basis
confirming the total premium you paid for these benefits.
Ask your pharmacist to provide you with a statement of all your claims for
the past year. The statement will show what was paid by your provincial
plan and what was paid by you or Sun Life (insurer of the CAAT Retirees Plan)
If you have signed up for access to your records on Sun Life’s website,
you may print off a statement of all your claims for the previous calendar
year showing the amount paid by the plan.
Use these two statements to track eligible medical expenses not paid by
your provincial medicare plan or your CAAT Retiree plan as these may be
used as medical expenses when you file your tax return.
________________________________________________________________________ Volume 2 – November 2011
CAAT Retiree Group Insurance Advisory Committee
FDA NEWS RELEASE: PPI Warning For Immediate Release : May 25, 2010 Media Inquiries: Elaine Gansz Bobo, 301-796- FDA: Possible Fracture Risk with High Dose, Long-term Use of Proton Pump Inhibitors The U.S. Food and Drug Administration today warned consumers and health care professionals about a possible increased risk of fractures of the hip, wrist, and spine with high doses or long
Osteoporosis Introduction Osteoporosis is a systemic skeletal disease characterizes by low bone mass and micro-architectural deterioration of bone tissue with a consequent increase in bone fragility and susceptibility to fracture. Osteoporosis is a generalized reduction in bone density that results when the rate of bone resorption exceeds the rate of bone formation. It is most commonly ass